注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Becton Dickinson and Co是一家全球性医疗技术公司。该公司从事医疗机构、医生、生命科学研究人员等使用的一系列医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。该公司的BD医疗部门生产一系列医疗技术和设备,用于帮助改善各种环境下的医疗保健服务。BD Medical部门由多个业务部门组成,包括药物输送解决方案、药物管理解决方案和制药系统。该公司的BD Life Sciences部门提供用于收集和运输诊断标本的产品,以及检测各种传染病、医疗保健相关感染和癌症的仪器和试剂系统。该公司的BD介入部门提供血管、泌尿科、肿瘤学和外科专业产品。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Thomas E. Polen | 48 | 2014 | President, CEO & Chairman |
Bertram Lee Scott | 72 | 2002 | Lead Independent Director |
Catherine M. Burzik | 73 | 2013 | Independent Director |
Claire M. Fraser-Liggett | 68 | 2006 | Member of Scientific Advisory Board & Independent Director |
John A. DeFord | 61 | 2018 | Co-Chair of Scientific Advisory Board |
Christopher Ian Montague Jones | 68 | 2010 | Independent Director |
Jeffrey W. Henderson | 58 | 2018 | Independent Director |
Robert Andrew Eckert | 61 | 2016 | Independent Director |
William M. Brown | 61 | 2022 | Independent Director |
Joanne Waldstreicher | 62 | 2023 | Independent Director |
Eric Perakslis | - | 2022 | Member of Scientific Advisory Board |
Jay J. Schnitzer | - | 2022 | Member of Scientific Advisory Board |
Timothy M. Ring | 66 | 2017 | Independent Director |
Ken Sands | - | 2022 | Member of Scientific Advisory Board |
Carrie L. Byington | 60 | 2021 | Independent Director |
Martha L. Gray | - | 2022 | Member of Scientific Advisory Board |
Joseph M. Smith | - | 2021 | Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核